Warum Bitcoin als Wertspeicher in keinem diversifizierten Portfolio fehlen sollte. Jetzt lesen -w-
12.09.2015 15:00:20

Baker Bros. Advisors Buys 2.48 Mln More Shares In Aquinox

(RTTNews) - Aquinox Pharmaceuticals, Inc. (AQXP) disclosed in a filing with the U.S. Securities and Exchange Commission that 667, L.P. and Baker Brothers Life Sciences, L.P. purchased 266,563 shares and 2.21 mil667, L.P.lion shares, respectively, of the company's common stock at the offering price of $15.50 per share on September 10, 2015.

On September 9, 2015, Aquinox entered into an underwriting agreement with Leerink Partners LLC, related to a public offering of 5.50 million shares of its common stock at a price to the public of $15.50 per share. Pursuant to this offering, the Funds purchased 2.48 million shares.

According to the filing, of the 17.05 million shares total shares outstanding following the offering, 667, L.P. owns 4.3 percent of class outstanding and Baker Brothers Life Sciences, L.P. owns 35.3 percent of class outstanding, resulting in Baker Bros. Advisors LP owning aggregate 39.6 percent of the shares.

AQNX closed Friday's regular trading at $17.26.

Nachrichten zu Aquinox Pharmaceuticals Incmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Aquinox Pharmaceuticals Incmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!